Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Smo receptor-specific Hh signaling inhibitor LY2940680
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Smoothened Receptor Antagonist LY294068, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients with Localized Esophageal or Gastroesophageal Junction Cancer
Status: Not yet active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0966, NCI-2015-01554, NCT02530437
Start Over